The neurochemistry of autism

R Marotta, MC Risoleo, G Messina, L Parisi… - Brain sciences, 2020 - mdpi.com
Autism spectrum disorder (ASD) refers to complex neurobehavioral and
neurodevelopmental conditions characterized by impaired social interaction and …

Nicotinic ACh receptors as therapeutic targets in CNS disorders

KT Dineley, AA Pandya, JL Yakel - Trends in pharmacological sciences, 2015 - cell.com
The neurotransmitter acetylcholine (ACh) can regulate neuronal excitability by acting on the
cys-loop cation-conducting ligand-gated nicotinic ACh receptor (nAChR) channels. These …

Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders

HO Kalkman, D Feuerbach - Cellular and molecular life sciences, 2016 - Springer
The clinical development of selective alpha-7 nicotinic acetylcholine receptor (α7 nAChR)
agonists has hitherto been focused on disorders characterized by cognitive deficits (eg …

Autism: Pathophysiology and promising herbal remedies

M Bahmani, A Sarrafchi, H Shirzad… - Current …, 2016 - ingentaconnect.com
Autism is a comprehensive growth abnormality in which social skills, language,
communication, and behavioral skills are developed with delay and as diversionary. The …

Role of neuroinflammation in autism spectrum disorder and the emergence of brain histaminergic system. Lessons also for BPSD?

N Eissa, A Sadeq, A Sasse, B Sadek - Frontiers in pharmacology, 2020 - frontiersin.org
Many behavioral and psychological symptoms of dementia (BPSD) share similarities in
executive functioning and communication deficits with those described in several …

A machine learning approach for understanding the metabolomics response of children with autism spectrum disorder to medical cannabis treatment

JC Quillet, M Siani-Rose, R McKee, B Goldstein… - Scientific Reports, 2023 - nature.com
Autism spectrum disorder (ASD) is a neurodevelopmental condition impacting behavior,
communication, social interaction and learning abilities. Medical cannabis (MC) treatment …

Potential therapeutic use of the ketogenic diet in autism spectrum disorders

E Napoli, N Dueñas, C Giulivi - Frontiers in pediatrics, 2014 - frontiersin.org
The ketogenic diet (KGD) has been recognized as an effective treatment for individuals with
glucose transporter 1 (GLUT1) and pyruvate dehydrogenase (PDH) deficiencies as well as …

Systematic review and meta-analysis: pharmacological and nonpharmacological interventions for persistent nonepisodic irritability

R Breaux, R Baweja, HM Eadeh, DM Shroff… - Journal of the American …, 2023 - Elsevier
Objective This meta-analysis examined the efficacy of available pharmacological and
nonpharmacological interventions for irritability among youth with autism spectrum disorder …

[HTML][HTML] Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial

FM Consolim-Colombo, CT Sangaleti, FO Costa… - JCI insight, 2017 - ncbi.nlm.nih.gov
BACKGROUND. Metabolic syndrome (MetS) is an obesity-driven condition of pandemic
proportions that increases the risk of type 2 diabetes and cardiovascular disease …

N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy …

M Nikoo, H Radnia, M Farokhnia… - Clinical …, 2015 - journals.lww.com
Objectives According to the proposed interference of N-acetylcysteine (NAC) with
pathophysiologic processes of autistic disorders (ADs), we aimed to assess the …